Out-licensing: Diagnostic/Biomarker-based Diagnostics

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..20 of 54 - per page Previous page Next page
Order by

A MicroRNA Profile for Androgen Responsive Prostate Cancer

A microRNA gene expression profile in prostate cancers that correlates with androgen responsiveness More

Methods and Composition for the Detection and Treatment of HIV-1

Monoclonal antibody for a novel HIV protein with potential diagnostic, prognostic, and therapeutic uses. More

A Gene Expression Signature Identifying Pro-Angiogenic Genes in Ovarian Tumor Endothelial Cell Isolates

Unique proangiogenic biomarkers isolated from ovarian endothelial cells More

Cripto-1 as a Biomarker for Cardiac Ischemia

Cripto-1 is overexpressed in infarcted myocardial tissue More

Diagnostic and Therapeutic Use of Brother of the Regulator of Imprinted Sites (BORIS) Alternative Splice Forms

This technology identifies twenty five (25) new alternatively spliced transcripts of the BORIS gene. More

Gene Expression Profiling - High-Risk Entity of Multiple Myeloma (02-08)

Novel diagnostic and prognostic gene array classification system More

DLC-1 Gene Deleted in Cancers

Through in vitro and in vivo tumor suppression experiments, the inventors have demonstrated that DLC-1 acts as a new tumor suppressor gene for different types of human cancer. More

Specific Diagnostic for Aspiration and Gastroesophageal Reflux

A method for detecting pulmonary aspiration or gastroesophageal reflux comprising: orally administering to a subject a diagnostic composition comprising bio-degradable polymeric microspheres having a diameter of about 0.1-10 microns; obtaining... More

Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies

Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More

Gene Expression Signatures of High Risk MGUS to Multiple Myeloma transitions and Uses Thereof (17 GENE PROFILE) (07-24)

Prognostic Test / Diagnostic Screening Multiple Myeloma and other cancers More

Displaying 11..20 of 54 - per page Previous page Next page
Order by

Your selection

Industry sector: Diagnostic del; Biomarker-based diagnostics del

Browse By

Therapeutic target: Accident and Trauma; Allergy; Blood and forming organs; Cardiovascular; Central Nervous System; Dermatological; Endocrinology; Gastrointestinal; Genetic disorders; Genito-urinary; Hospital and Surgery; Immune related disorders; Infectious diseases; Metabolism; Musculoskeletal; Oncology; Oral Health; Other therapeutic; Respiratory; Sensory organ
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us